Description
Studies have shown that VIP helps reduce inflammation throughout the body and is particularly effective in neurodegenerative diseases, pulmonary fibrosis, inflammatory bowel disease, and cardiac fibrosis. The peptide appears to be very effective in a number of fibrotic pathways and has a curative effect on the normal process of fibrosis, which results in high rates of morbidity and mortality.
In addition to its antifibrotic effects, which appear to be mediated by anti-inflammatory action, VIP is also a potent immune system regulator with an overall anti-inflammatory effect. The peptide has also been shown to protect the central nervous system from stroke and is of active interest due to its ability to preserve cognitive function in the setting of neurodegenerative disease.
Reviews
There are no reviews yet.